期刊文献+

单用瑞芬太尼与芬太尼、瑞芬太尼复合应用对全麻苏醒拔管期心血管反应的影响 被引量:10

Comparison of the cardiovascular response at extubation period of general anesthetic postoperation using remifentanil only and remifentanil combined with fentanyl
下载PDF
导出
摘要 目的比较单用瑞芬太尼与芬太尼、瑞芬太尼复合应用对全麻苏醒拔管期心血管反应的影响。方法全麻行腹腔镜下胆囊切除术患者40例,ASA分级I-II级,随机分为两组:瑞芬太尼组(R组)和芬太尼+瑞芬太尼组(FR组),每组各20例。两组分别以瑞芬太尼1μg/kg和芬太尼5μg/kg复合咪达唑仑0.05mg/kg,维库溴铵0.1mg/kg,异丙酚1.5mg/kg诱导。两组均以瑞芬太尼0.2μg·kg-1·min-1复合异丙酚(5-6)mg·kg-1·h-1泵注维持麻醉,间断静注维库溴铵,手术结束时停用异丙酚和瑞芬太尼。观察麻醉前、拔管时、拔管后1min、拔管后5min、拔管后10min的平均动脉压和心率;观察患者呼吸恢复时间、睁眼时间、拔管时间。结果R组拔管时、拔管后1min、5min的平均动脉压和心率较FR组明显升高(P<0.05);两组呼吸恢复时间、睁眼时间、拔管时间差异无统计学意义。结论芬太尼瑞芬太尼复合应用较单用瑞芬太尼能更有效抑制全麻苏醒拔管期的心血管反应,且不延长苏醒时间。 Objective To compare the cardiovascular response at extubation period of general anesthetic postoperation using remifentanil only and remifentanil combined with fentanyl. Methods Forty ASA class Ⅰor Ⅱpatients of laparoscopic cholecystectomy were randomly and equally divided into remifentanil group (R) and fentanyl -remifentanil group(FR). Remifentanil 1 μg/kg in group R and fentanyl 5μg/kg in group FR combined with midazolam 0. 05 mg/kg, vecumnium 0.1 mg/kg and propofol 1.5 mg/kg were used for anesthesia induction. 0. 2μg · kg^-1 · h^-1 dose of remifentanil and 5 -6mg · kg^-1 · h^-1 dose of propofol were infused to maintain anesthesia. MAP, HR and the revival time were observed. Results MAP and HR in group R significantly rised compared with group FR at the time of extubation, 1 minute and 5 minutes after extubation (P 〈 0.05). The time of breathing recovery, eye opening, extubation had no significant difference in two groups. Conclusion Fentanyl combined with remifentanil can depress the cardiovascular response at extubation period of general anesthetic postoperation more effectively than remifentanil only, meanwhile, does not prolong revival time.
出处 《海南医学》 CAS 2009年第9期24-25,23,共3页 Hainan Medical Journal
关键词 瑞芬太尼 芬太尼 全麻 拔管 Remifentanil Fentanyl General anesthesia Extubation
  • 相关文献

参考文献5

  • 1杨承祥.麻醉恢复期的严重并发症.见:曾因明,邓小明,主编.麻醉学新进展.北京:人民卫生出版社,2006.590-602.
  • 2盛娅仪,徐振邦.瑞芬太尼的药理学和临床应用[J].中国新药与临床杂志,2001,20(2):142-146. 被引量:445
  • 3庄心良,曾因明,陈伯銮.现代麻醉学[M].3版.北京:人民卫生出版社,2006:525.
  • 4Glass PS , Gan TJ , Howell S. A review of the pharmacokinetics and pharmaco dynamics of remifentanil [ J ]. Anesth Analg, 1999, 89(4): 7- 14.
  • 5Johannsen EK, Munro AJ. Remifentanil in emergency caesarean section in pre - eclampsia complicated by thrombocytopenia and abnormal liver function[J]. Anesth Intensive Care,1999,27(5):527 - 529.

二级参考文献4

  • 1曾慎健.艾司洛尔的临床应用[J].新药与临床,1989,8(3):152-154. 被引量:3
  • 2Glass P S,Anesth Analg,1999年,89卷,S7页
  • 3Kan R E,Anesthesiology,1998年,88卷,1467页
  • 4曹慎健,新药与临床,1989年,8卷,152页

共引文献446

同被引文献64

  • 1刘冬俊,郜红艳.依托米酯与丙泊酚在高血压病人腹腔镜手术麻醉诱导中的应用[J].海南医学,2007,18(2):77-77. 被引量:2
  • 2孙明,巩红岩,张永强,陈胜阳.氟比洛芬酯脂微球载体注射液用于开胸患者超前镇痛与术后镇痛的比较[J].中国煤炭工业医学杂志,2007,10(7):811-812. 被引量:1
  • 3曾因明,邓小明 主译.米勒麻醉学[M].6版.北京:北京大学医学出版社.2006:2344-2434.
  • 4陈艾芳,陈冬梅.不同剂量艾司洛尔对高血压及冠心病病人围拔管期心血管反应的影响[J].内蒙古医学院院报,2010,32(1):54-55.
  • 5Mangano DT, Dennis T. Perioperative cardiac morbidity [J], Anes-thesiology, 1990, 72(1): 153-184.
  • 6Junghans T, Bohm B,Grundet K, et al. Effects of pneumoperitone-um with carbon dioxide, argon, or helium on hemodynamic and re-spiratory function [J]. Arch Surg, 1997,132(3): 272-278.
  • 7Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine: a re-view of clinical applications [J]. Curr Op in Anaesthesiol, 2008, 21(4): 457-461.
  • 8Wijeysundera DN, Bender JS, Beattie WS. Alpha-2 adrenergic ago-nists for the prevention of cardiac complications among patients un-dergoing surgery [J]. Cochrane Database Syst Rev, 2009,7(4):CD004126.
  • 9Menda F, Kner 0,Sayin M, et al. Dexmedetomidine as an adjunctto anesthetic induction to attenuate hemodynamic response to endo-tracheal intubation in patients undergoing fast-track CABG [J]. AnnCard Anaesth, 2010, 13(1): 16-21.
  • 10王敏.艾司洛尔对全麻高血压患者拔管期血流动力学的影响[J].浙江医学,2007,29(10):1112-1113. 被引量:5

引证文献10

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部